Beijing, China

Kaijing Guo


 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Kaijing Guo: Innovator in Pharmaceutical Chemistry

Introduction

Kaijing Guo is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine through his innovative research and development. His work primarily focuses on pharmaceutical chemistry, particularly in the area of drug formulation and application.

Latest Patents

Kaijing Guo holds a patent for a maleate of a nicotinyl alcohol ether derivative, along with its crystal form and applications. This invention relates to the technical field of medicine and specifically addresses the (S)-N-(2-(pyridin-3-yl-methoxy)-4-(2-bromo-3-phenylbenzyloxy)-5-chlorobenzyl) serine isopropyl ester maleate. The patent outlines a preparation method, a pharmaceutical composition, and the use of this compound in treating diseases associated with the PD-1/PD-L1 signaling pathway, including cancer, infectious diseases, and autoimmune diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Kaijing Guo has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Tianjin Chase Sun Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kaijing Guo has collaborated with notable colleagues, including Zhiqiang Feng and Xiaoguang Chen. These partnerships have enhanced his research capabilities and have led to advancements in pharmaceutical innovations.

Conclusion

Kaijing Guo is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach and dedication to research continue to drive advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…